2020 Update on Esophageal Cancer: Does the Addition of Trastuzumab to Trimodality Treatment Improve DFS in HER2 Overexpressing Esophageal Adenocarcinoma?

759 views
August 6, 2020
Comments 1
Login to view comments. Click here to Login